Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

about

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

Item

http://www.wikidata.org/entity/Q58106291

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Sirolimus is efficacious in tr ...... ric prospective phase II study

@en

Sirolimus is efficacious in tr ...... ric prospective phase II study

@nl

type

Item

label

Sirolimus is efficacious in tr ...... ric prospective phase II study

@en

Sirolimus is efficacious in tr ...... ric prospective phase II study

@nl

prefLabel

Sirolimus is efficacious in tr ...... ric prospective phase II study

@en

Sirolimus is efficacious in tr ...... ric prospective phase II study

@nl

P1476

Sirolimus is efficacious in tr ...... ric prospective phase II study

@en

P2093

An Van Damme

http://www.w3.org/2001/XMLSchema#string

Caroline Chopinet

http://www.w3.org/2001/XMLSchema#string

Claire Hoyoux

http://www.w3.org/2001/XMLSchema#string

Emmanuel Seront

http://www.w3.org/2001/XMLSchema#string

Frank Hammer

http://www.w3.org/2001/XMLSchema#string

Jennifer Hammer

http://www.w3.org/2001/XMLSchema#string

Laurence M Boon

http://www.w3.org/2001/XMLSchema#string

Philippe Clapuyt

http://www.w3.org/2001/XMLSchema#string

Sandra Schmitz

http://www.w3.org/2001/XMLSchema#string

Sophie Dupont

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies

Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects

Allelic and locus heterogeneity in inherited venous malformations

Somatic Activating PIK3CA Mutations Cause Venous Malformation

User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability

[Medical and surgical treatment of venous malformations]

[Vascular tumours and malformations, classification, pathology and imaging]

Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.

Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics.

P2888

s13023-018-0934-z

P304

191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13023-018-0934-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Miikka Vikkula

P577

2018-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107908990

http://www.w3.org/2001/XMLSchema#string

P698

30373605

http://www.w3.org/2001/XMLSchema#string

P932

6206885

http://www.w3.org/2001/XMLSchema#string